ICE Pharma Group (IPG) is a generic pharmaceutical company with its own Marketing Authorisations (MAs) and experienced operational teams who can manage the manufacturing process through to a final product release into the European market. IPG is MHRA approved, holds GMP and GDP certification, and has approvals to import both APIs and Finished Drugs from outside Europe. We have Manufacturing and Importation Authorisation (MIA) and Wholesale Distribution Authorisation (WDA) for import and sales of products in Europe.
IPG was founded in the UK in 1999 to source API’s and intermediates. The company achieved early success in introducing new Indian and Chinese manufacturers to the generics sector. Eventually moving up the value chain, IPG has built extensive experience through a range of projects and has built a network of highly skilled industry experts in manufacturing generic products, owning licenses and providing support services to new MAH’s and more. IPG has also helped launch numerous new generics onto the world markets; providing its customers and partners with technical and commercial expertise, critical to successful project implementation.
To be a recognized leader in managing highly complex global supply chain projects for the regulated healthcare sector and a leader in product sourcing and management of all aspects of EU based healthcare operations.
To increase access to essential medical and healthcare products at a lower cost, but with quality assured.